Tamtam Try Tamtam free
Alan logo

Alan account plan

Health insurance provider

At a glance

Alan is a French prevention health insurer with €804m signed ARR (Q1 2026), about 1.14 million members and over 850 employees in four countries.

Alan, founded in 2016 by Jean-Charles Samuelian-Werve and Charles Gorintin, is a licensed health insurer that carries the risk itself and bundles cover with prevention services, care navigation, in-app doctors and Mo, its AI health companion. It insures employees of companies from one-person firms to large groups and public bodies, plus self-employed people and retirees, in France, Belgium, Spain and Canada, with more than 37,000 businesses as clients. It finished Q1 2026 with €804m in signed ARR and 1.1 million members, growing 53% year on year, and is profitable in France on an EBITDA basis. It has over 850 employees and is privately held; in June 2026 Prosus led a €480m Series G at a €5.5bn valuation.

Business units

Strategic priorities

International expansion
The CEO aims to double the number of countries in the next 18 months, not only in Europe, and says Alan went from three countries to six; the Q2 2026 letter says several new markets beyond Europe and Canada are at an advanced stage.
From insurer to integrated healthcare platform
Alan is consolidating prevention, access and wellbeing products and integrating them more deeply with insurance, aiming to lower its cost of claims through prevention.
AI-native operations
40% of care conversations are automated, agentic processes cover claims, fraud, underwriting and operations, and sales AI is on track for ~30% productivity gains in 2026.
Global multi-country tech stack
Alan is rebuilding its technical stack into a global, multi-country architecture to enter new markets and reach new segments faster.
Public sector and new segments
After winning ministries, Alan says a few major public tenders are underway, and it is growing strongly with retirees and the self-employed.
Global brand
Health Can't Wait, a new global brand platform, was finalised in Q2 2026, with a first global campaign later in the year.

Latest results

Alan finished Q1 2026 with €804m in signed ARR and 1.1 million members; new business acquisition rose 60% versus the previous year with roughly similar investments. By the end of Q2 2026 it had about 1.14 million members, and in September 2026 the CEO cited 1.2 million people covered and ARR growing 55% year on year. It is profitable in France and, per the CEO in October 2026, almost break even at group level, with several hundred million euros in cash. No numerical guidance is given.

Investments and deals

Series G led by Prosus
€480m at a €5.5bn valuation in June 2026, with Teachers' Venture Growth, Index Ventures and new investor Dara Holdings; total funding now past €1.2bn. Three months earlier Alan raised €100m at a €5bn valuation.
Acquisition of Aro
Alan Précision was built following the acquisition of Aro; the Series G is also earmarked for fresh acquisitions.
AI and product development
The round funds heavy spending on AI and health services, through technical teams rather than training large models, including Mo and the autonomous coding agent Hopper.
Occupational-health centre
The Prévenir medical centre at Alan's Paris office, completed at the end of Q1 2026.

Challenges and risks

Proving prevention works at scale
The Next Web notes that insurers have promised to reward healthy behaviour for years with mixed results; showing that app nudges and AI improve health at scale is still to be proven.
Capital-intensive model
Insurance needs reserves and expansion needs more capital; Alan is profitable in France but only almost break even at group level.
Regulation across new markets
Each new country needs licences and regulatory processes; the Series G itself needed sign-off from France's financial authorities, and new country names are withheld pending regulators.
AI regulation in Europe
The CEO opposes local AI regulation he says harms the industry and wants simpler rules, while Alan relies on AI in all functions.

What leadership says

“Health can't wait, not for symptoms to get worse, not for a six-month appointment, not for the system to catch up... We believe great health is a universal right, and that prevention should be too.”

Jean-Charles Samuelian-Werve, Co-founder and CEO · The Next Web, Alan raises €480M led by Prosus, 2026-06-25

“Our sales team has doubled productivity in the in the last 2 years”

Jean-Charles Samuelian-Werve, Co-founder and CEO · Couchonomics with Arjun podcast, 2026-09-29

“We have more growth in front of us than behind us”

Jean-Charles Samuelian-Werve, Co-founder and CEO · 2026 Q2 Letter to Shareholders, 2026-08-31

“Healthcare presents one of the most significant global opportunities for AI-led transformation”

Fahd Beg, Head of investments, Prosus Group · The Next Web, Alan raises €480M led by Prosus, 2026-06-25

Where a supplier can help

Market-entry services
Doubling the number of countries in 18 months creates needs for local recruitment, regulatory and actuarial advice, localisation and B2B distribution partners.
Healthcare provider and diagnostics partnerships
Alan Précision, telemedicine and occupational health depend on lab, clinic and medical partners, in line with the shift to an integrated healthcare platform.
AI and data infrastructure
AI-native operations and the global multi-country stack open room for AI tooling, evaluation, security and cloud suppliers that meet health-data rules.
Employer and public-sector channels
Public tenders and the employer channel call for HR-software integrations, benefits platforms and bid support.
Brand and wellbeing content
The global brand campaign and Alan Play's activity challenges fit media, sports and rewards partners.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Alan?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Alan

What does Alan do?

Alan is a licensed health insurer that bundles health cover with prevention services, care navigation, in-app doctors and Mo, its AI health companion, for companies, self-employed people and retirees.

What is Alan's revenue?

Alan finished Q1 2026 with €804m in signed ARR, growing 53% year on year; in October 2026 its CEO cited a turnover of 850 million.

How many employees does Alan have?

Over 850 employees, according to The Next Web in June 2026; the CEO cited roughly 900 people in September 2026.

Who leads Alan?

Jean-Charles Samuelian-Werve is co-founder and CEO; Charles Gorintin is the other co-founder.

What is Alan's strategy?

Become an integrated prevention and healthcare platform, expand to new countries beyond Europe and Canada, and run an AI-native operating model on a global tech stack.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)